The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover

被引:156
作者
Aleksandrov, L [1 ]
Aleksandrov, AA [1 ]
Chang, XB [1 ]
Riordan, JR [1 ]
机构
[1] Mayo Fdn & Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA
关键词
D O I
10.1074/jbc.M111713200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As in other adenine nucleotide binding cassette (ABC) proteins the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR) bind and hydrolyze ATP and in some manner regulate CFTR ion channel gating. Unlike some other ABC proteins, however, there are preliminary indications that the two domains of CFTR are nonequivalent in their nucleotide interactions (Szabo, K., Szakacs, G., Hegeds, T., and Sarkadi, B. (1999) J. Biol. Chem. 274,12209-12212; Aleksandrov, L., Mengos, A., Chang, X., Aleksandrov, A., and Riordan, J. R. (2001) J. Biol. Chem. 276, 1291812923). We have now characterized the interactions of the 8-azido-photoactive analogues of ATP, ADP, and 5'-adenyl-beta,gamma-imidodiphosphate (AMP-PNP) with the two domains of functional membrane-bound CFTR. The results show that the two domains appear to act independently in the binding and hydrolysis of 8-azido-ATP. At NBD1 binding does not require a divalent cation. This binding is followed by minimal Mg2+-dependent hydrolysis and retention of the hydrolysis product, 8-azido-ADP, but not as a vanadate stabilized post-hydrolysis transition state complex. In contrast, at NBD2, MgN(3)ATP is hydrolyzed as rapidly as it is bound and the nucleoside diphosphate hydrolysis product dissociates immediately. Confirming this characterization of NBD1 as a site of more stable nucleotide interaction and NBD2 as a site of fast turnover, the non-hydrolyzable N(3)AMP-PNP bound preferentially to NBD1. This demonstration of NBD2 as the rapid nucleotide turnover site is consistent with the strong effect on channel gating kinetics of inactivation of this domain by mutagenesis.
引用
收藏
页码:15419 / 15425
页数:7
相关论文
共 43 条
  • [1] The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating
    Aleksandrov, AA
    Chang, XB
    Aleksandrov, L
    Riordan, JR
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2000, 528 (02): : 259 - 265
  • [2] Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator
    Aleksandrov, L
    Mengos, A
    Chang, XB
    Aleksandrov, A
    Riordan, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12918 - 12923
  • [3] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [4] ATPase activity of purified multidrug resistance-associated protein
    Chang, XB
    Hou, YX
    Riordan, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30962 - 30968
  • [5] CHANG XB, 1993, J BIOL CHEM, V268, P11304
  • [6] The human ATP-binding cassette (ABC) transporter superfamily
    Dean, M
    Rzhetsky, A
    Allikmets, R
    [J]. GENOME RESEARCH, 2001, 11 (07) : 1156 - 1166
  • [7] Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis
    Diederichs, K
    Diez, J
    Greller, G
    Müller, C
    Breed, J
    Schnell, C
    Vonrhein, C
    Boos, W
    Welte, W
    [J]. EMBO JOURNAL, 2000, 19 (22) : 5951 - 5961
  • [8] Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator - Production of a suitable protein for structural studies
    Duffieux, F
    Annereau, JP
    Boucher, J
    Miclet, E
    Pamlard, O
    Schneider, M
    Stoven, V
    Lallemand, JY
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (17): : 5306 - 5312
  • [9] NUCLEOSIDE PHOSPHOROTHIOATES
    ECKSTEIN, F
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1985, 54 : 367 - 402
  • [10] GADSBY DC, 1999, PHYSIOL REV, V79, P77